PharmaNordic ApS: Financial statements 2020
CVR: 36408464
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
PharmaNordic ApS (CVR 36408464) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 516,628 and a net result of DKK 574,368 compared with DKK -87,787 the year before. That is an increase of 78.8% compared with the year before. Equity in the 2020 report amounted to DKK 345,503. The solvency ratio was 45%.
- Gross Profit
- DKK 516,628
- Profit/Loss
- DKK 574,368
- Equity
- DKK 345,503
- Total Assets
- DKK 767,827
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 517 t. | 574 t. | 346 t. | - |
| 2019 | - | 289 t. | -88 t. | -229 t. | - |
| 2018 | - | 476 t. | 109 t. | -141 t. | - |
| 2017 | - | 242 t. | -51 t. | -251 t. | - |
| 2016 | - | 190 t. | -65 t. | -199 t. | - |
Official annual report
How creditworthy is PharmaNordic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
PharmaNordic ApS has published its annual report for 2019. Gross profit came to DKK 289,021, and the net result was DKK -87,787.
About PharmaNordic ApS
PharmaNordic ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2014. The company is registered under the industry Planlægning og design af reklamekampagner. The management consists of Anders Lentini From. The company is owned by LENTINI HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -197,662 and a net result of DKK 2,313,695 compared with DKK 647,775 the year before. Equity in the 2025 report amounted to DKK 4,025,013.